Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Plasmacytoid dendritic cells and autoimmune inflammation.
Diaphragm breathing movement measurement using ultrasound and radiographic imaging: a concurrent validity.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Gas6 enhances axonal ensheathment by MBP+ membranous processes in human DRG/OL promyelinating co-cultures.
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Sexual disorders in women with MS: Assessment and management.
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
HIV immunodynamics and multiple sclerosis.
Exercise and cognition in multiple sclerosis: The importance of acute exercise for developing better interventions.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Olfactory memory impairment in neurodegenerative diseases.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
Risk factors for falls in multiple sclerosis: an observational study.
Pages
« first
‹ previous
…
452
453
454
455
456
457
458
459
460
…
next ›
last »